Get the Stockscreener App
6.64
5.90%
0.37
After Hours:
6.70
0.06
+0.90%
Personalis Inc stock is traded at $6.64, with a volume of 741.45K.
It is up +5.90% in the last 24 hours and up +70.69% over the past month.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
See More
Previous Close:
$6.27
Open:
$6.31
24h Volume:
741.45K
Relative Volume:
0.83
Market Cap:
$562.36M
Revenue:
$73.48M
Net Income/Loss:
$-108.30M
P/E Ratio:
-2.9511
EPS:
-2.25
Net Cash Flow:
$-67.17M
1W Performance:
+13.12%
1M Performance:
+70.69%
6M Performance:
+457.98%
1Y Performance:
+240.51%
1-Day Range:
$6.25
$6.73
1-Week Range:
$5.48
$6.73
52-Week Range:
$1.12
$7.20
Personalis Inc Stock (PSNL) Company Profile
Name
Personalis Inc
Sector
Industry
Phone
650-752-1300
Address
6600 DUMBARTON CIRCLE, FREMONT, CA
Compare PSNL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
6.64 | 562.36M | 73.48M | -108.30M | -67.17M | -2.25 |
|
TMO
Thermo Fisher Scientific Inc
|
532.02 | 203.50B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
234.84 | 169.62B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
135.69 | 38.75B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.39 | 35.83B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
415.53 | 34.03B | 3.84B | 866.24M | 792.60M | 10.37 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-06-23 | Upgrade | Needham | Hold → Buy |
| Jan-07-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-05-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-03-21 | Downgrade | Needham | Buy → Hold |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-20-21 | Reiterated | Needham | Buy |
| May-06-21 | Upgrade | Oppenheimer | Perform → Outperform |
| Jan-28-21 | Initiated | Truist | Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-12-20 | Reiterated | Needham | Buy |
| Nov-06-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Aug-27-20 | Initiated | H.C. Wainwright | Buy |
| Aug-18-20 | Initiated | Needham | Buy |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Initiated | BofA/Merrill | Neutral |
| Jul-15-19 | Initiated | Cowen | Outperform |
| Jul-15-19 | Initiated | Morgan Stanley | Overweight |
| Jul-15-19 | Initiated | Oppenheimer | Outperform |
View All
Personalis Inc Stock (PSNL) Latest News
Personalis, Inc. (NASDAQ:PSNL) Stake Raised by State Street Corp - Defense World
Jane Street Group LLC Increases Stock Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World
Personalis, Inc. (NASDAQ:PSNL) Stock Position Reduced by Stifel Financial Corp - Defense World
Personalis, Inc. Amends Sales Agreement with Piper Sandler & Co. and BTIG - Defense World
The 16% return this week takes Personalis' (NASDAQ:PSNL) shareholders one-year gains to 159% - Yahoo Finance
Grail (NASDAQ:GRAL) & Personalis (NASDAQ:PSNL) Financial Contrast - Defense World
Local vaccine biotech secures $50 million Merck investment - The Business Journals
Personalis price target raised to $8 from $7 at BTIG - Yahoo Finance
Personalis Announces Investment Agreement with Merck in Latest 8-K Filing - Defense World
Personalis stock rallies 25% amid $50M Merck investment - MSN
Personalis shares target increased, buy rating on Merck investment By Investing.com - Investing.com
Personalis' (PSNL) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat
Personalis (NASDAQ:PSNL) Price Target Raised to $11.00 at HC Wainwright - MarketBeat
Personalis (NASDAQ:PSNL) shareholder returns have been solid, earning 248% in 1 year - Simply Wall St
Personalis (PSNL) Stock Jumps After-Market Following Major Business Moves - Stocks Telegraph
Personalis secures investment from Merck, extends Moderna deal By Investing.com - Investing.com Canada
Personalis, Inc. announced that it expects to receive $49.999997 million in funding from Merck Sharp & Dohme LLC - Marketscreener.com
Personalis Inc share price jumps 50% on deals with Merck and Moderna - Mugglehead
Personalis Secures $50M from Merck, Extends Collaboration with Moderna - HIT Consultant
Personalis Shares Surge After Merck's $50 Million Investment - MarketWatch
Merck Buys $50 Million of Personalis Stock - Marketscreener.com
Personalis Lands $50M Merck Investment, Extends Key Moderna Partnership for Cancer Therapy Platform - StockTitan
Personalis SVP sells $5,779 in stock - Investing.com India
Personalis CFO Aaron Tachibana sells $26,224 in stock By Investing.com - Investing.com Australia
Personalis CFO Aaron Tachibana sells $26,224 in stock - Investing.com India
Personalis SVP sells $5,779 in stock By Investing.com - Investing.com UK
Tempus AI, Inc (TEM) Expands Partnership with Personalis to Advance Ultra-Sensitive MRD Testing for Biopharma - Insider Monkey
Personalis and Tempus Expand Collaboration to Biopharma - sharewise
Personalis, Tempus Expand Partnership to Revolutionize Cancer Detection with Advanced MRD Testing - StockTitan
Personalis, Inc. and Tempus AI, Inc. Expand Collaboration to Biopharma - Marketscreener.com
Jacobs Levy Equity Management Inc. Sells 329,335 Shares of Personalis, Inc. (NASDAQ:PSNL) - MarketBeat
Walleye Capital LLC Buys Shares of 166,788 Personalis, Inc. (NASDAQ:PSNL) - MarketBeat
Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.
Personalis CFO Aaron Tachibana sells $4,953 in stock By Investing.com - Investing.com Australia
Personalis SVP sells $6,416 in stock - Investing.com India
Personalis CFO Aaron Tachibana sells $4,953 in stock - Investing.com India
Personalis SVP sells $6,416 in stock By Investing.com - Investing.com Nigeria
Personalis to Participate at Upcoming Investor Conferences - The Bakersfield Californian
Personalis, Inc. (NASDAQ:PSNL) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St
Personalis, Inc. (NASDAQ:PSNL) Shares Sold by GSA Capital Partners LLP - MarketBeat
Personalis Inc. (PSNL) Quarterly 10-Q Report - Quartzy
FY2024 EPS Estimate for Personalis Decreased by Analyst - Defense World
FY2024 EPS Estimates for Personalis Cut by HC Wainwright - MarketBeat
Here's Why We're Not Too Worried About Personalis' (NASDAQ:PSNL) Cash Burn Situation - Yahoo Finance
Personalis, Inc. (NASDAQ:PSNL) Q3 2024 Earnings Call Transcript - Insider Monkey
Personalis Inc Stock (PSNL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Personalis Inc Stock (PSNL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Moore Stephen Michael | SVP and Chief Legal Officer |
Dec 16 '24 |
Sale |
3.82 |
1,513 |
5,780 |
65,875 |
| Tachibana Aaron | CFO AND COO |
Dec 16 '24 |
Sale |
3.82 |
6,865 |
26,224 |
167,098 |
| Tachibana Aaron | CFO AND COO |
Nov 18 '24 |
Sale |
3.79 |
1,307 |
4,954 |
173,963 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
Nov 18 '24 |
Sale |
3.79 |
1,693 |
6,416 |
67,388 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Nov 18 '24 |
Sale |
3.79 |
921 |
3,491 |
128,720 |
| Hall Christopher M | PRESIDENT AND CEO |
Nov 01 '24 |
Sale |
5.38 |
26,443 |
142,263 |
178,098 |
| Tempus AI, Inc. | 10% Owner |
Aug 16 '24 |
Buy |
5.07 |
3,500,000 |
17,745,000 |
12,718,800 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jul 30 '24 |
Sale |
2.97 |
524 |
1,556 |
127,227 |
| Tachibana Aaron | CFO AND COO |
Jul 30 '24 |
Sale |
2.97 |
742 |
2,204 |
175,270 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jun 17 '24 |
Sale |
1.29 |
5,055 |
6,521 |
127,751 |
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):